PANGOLIN THERAPEUTICS
Pangolin Therapeutics develops a chemistry-driven platform to design novel small molecule therapeutics. Pangolin specializes in research in neurodegenerative diseases, including Parkinson's and Alzheimer's. The plaform is designed to target the disassembly of toxic protein oligomers during disease pathogenesis.
PANGOLIN THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Guilford, Connecticut, United States
Country:
United States
Website Url:
http://www.pangolintherapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Curionic Biotherapeutics
Curionic Biotherapeutics develops a platform technology designed to discover protein therapeutics.
Current Employees Featured
Founder
Official Site Inspections
http://www.pangolintherapeutics.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pangolin Therapeutics"
Home - Pangolin Therapeutics
Pangolin Therapeutics uses a combination of molecular modeling, biophysics, synthetic organic chemistry and other tools of drug discovery to produce …See details»
Pangolin Therapeutics - Crunchbase Company Profile & Funding
Pangolin Therapeutics develops a chemistry-driven platform to design novel small molecule therapeutics. Pangolin specializes in research in neurodegenerative diseases, including …See details»
Pangolin Therapeutics, Inc. - BioCT
Email: [email protected] General Information: Pangolin Therapeutics, Inc. is a chemistry-driven platform company using Yale Professor and Co-founder Andrew Miranker’s Pangomer TM technology to design novel …See details»
Susan Froshauer, PhD | Yale Ventures
Susan Froshauer, Ph.D. Susan has over 30 years of R & D experience in the pharmaceutical industry, most recently as founding CEO of the Yale start-up Pangolin Therapeutics …See details»
Pangolin Therapeutics, Inc. Company Profile | Guilford, CT ...
Find company research, competitor information, contact details & financial data for Pangolin Therapeutics, Inc. of Guilford, CT. Get the latest business insights from Dun & Bradstreet.See details»
Pangolin Therapeutics - PitchBook
Pangolin Therapeutics General Information Description. Developer of a chemistry-driven platform intended to design novel small molecule therapeutics. The company specializes in research in neurodegenerative diseases, …See details»
Pangolin Therapeutics - Overview, News & Similar companies
Popular Searches Pangolin Therapeutics Inc Pangolintherapeutics SIC Code 80,804 NAICS Code 62,621 Show more. Pangolin Therapeutics Org Chart. Susan Froshauer. President & Chief …See details»
Pangolin Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Pangolin Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Pangolin Therapeutics - Products, Competitors, Financials, …
Pangolin Therapeutics focuses on developing a diverse class of therapeutic agents targeting toxic intrinsically disordered proteins (IDPs) involved in diseases such as Type 2 Diabetes, …See details»
Pangolin Therapeutics, Inc.:Company Profile & Technical Research ...
Https://pangolintherapeutics.com. Pangolin Therapeutics is a company that provides Small molecule and more. Pangolin Therapeutics is headquartered in United States Connecticut. …See details»
Pangolin Therapeutics - Founders and Board of Directors - Tracxn
Pangolin Therapeutics founders & board of directors. Provider of drug candidate identifications solutions for drug development. 2019 • Guilford (United States) • Funding Raised • Guilford …See details»
Pangolin Therapeutics - VentureRadar
Website: https://pangolintherapeutics.com/ Pangolin Therapeutics provides Pangomer Platform: A novel chemistry platform that targets toxic protein mis-assembly in ...See details»
Contact - Pangolin Therapeutics
Contact Pangolin Therapeutics today to learn more about our approach or to discuss investment opportunities.See details»
Pangolin Therapeutics - Company Profile - Tracxn
Pangolin Therapeutics - Provider of drug candidate identifications solutions for drug development. Raised funding from 1 investor. Founded by Andrew Miranker and Enrique Alvarez Sotomayor …See details»
BioCT welcomes new member Pangolin Therapeutics
BioCT welcomes new member Pangolin Therapeutics. Pangolin Therapeutics is a chemistry-driven platform company using Yale Professor and Co-founder Andrew Miranker’s Pangomer …See details»
Privacy Policy - Pangolin Therapeutics
Sep 10, 2020 For example, we may provide your Person Information to an organization in order to deliver information you have requested. We will also disclose information if we reasonably …See details»
Susan Froshauer - President & Chief Executive Officer at
President & Chief Executive Officer at Pangolin Therapeutics. Susan Froshauer is the President & Chief Executive Officer at Pangolin Therapeutics based in Guilford, Connecticut.See details»
Pangolin Therapeutics website goes live - Clarity Quest
Sep 17, 2020 The Pangomer ™ Platform is a “novel chemistry platform that targets toxic protein mis‑assembly in neurodegenerative and metabolic diseases.” Read more about their …See details»
Pangolin Therapeutics - VentureRadar
Ambagon applies deep knowledge of 14-3-3 proteins and a proprietary suite of drug discovery tools to create molecular glues that stabilize 14-3-3:target complexes.See details»
Revealed: How global financial giants invest in firm that makes ...
Dec 3, 2020 Revealed: How global financial giants invest in firm that makes medicines from endangered pangolin parts. We are working with conservation charity Space for Giants to …See details»